Dr Reddy's Laboratories (RDY) ADR Each Representing 1/2 INR5

Sell:$14.57Buy:$14.58$0.05 (0.31%)

Prices delayed by at least 15 minutes
Sell:$14.57
Buy:$14.58
Change:$0.05 (0.31%)
Prices delayed by at least 15 minutes
Sell:$14.57
Buy:$14.58
Change:$0.05 (0.31%)
Prices delayed by at least 15 minutes

Company Information

About this company

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Key people

Kallam Satish Reddy
Executive Chairman of the Board
Gunupati Venkateswara Prasad
Executive Co-Chairman, Managing Director
Erez Israeli
Chief Executive Officer
Mannam Venkata Narasimham
Chief Financial Officer
Patrick Aghanian
Chief Executive Officer, European Generics
M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Deepak Sapra
Chief Executive Officer - API and Services
Archana Bhaskar
Chief Human Resources Officer
Phanimitra B
Chief Digital and Information Officer
K. Randhir Singh
Compliance Officer, Company Secretary, Head - CSR
Leo Puri
Lead Non-Executive Independent Director
Claudio Albrecht
Non-Executive Independent Director
Kodumudi Pranathart Krishnan
Non-Executive Independent Director
Arun Madhavan Kumar
Non-Executive Independent Director
Sanjiv Soshil Mehta
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    DRREDDY
  • Location
    India
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US2561352038
  • Market cap
    $12.18bn
  • Employees
    26,944
  • Shares in issue
    834.58m
  • Exchange
    National Stock Exchange of India
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.